US Stock MarketDetailed Quotes

IONS Ionis Pharmaceuticals

Watchlist
  • 33.190
  • +1.840+5.87%
Close Feb 28 16:00 ET
  • 33.190
  • 0.0000.00%
Post 20:01 ET
5.28BMarket Cap-10.92P/E (TTM)

Ionis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ionis Pharmaceuticals Q4 2024 Earnings Date

Currency：USDFeb 19, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
139.18M
226.58M
+87.40M
Beat Est.
-57.18%
-30.18%
+62.80%
EPS
-1.13
-0.66
+0.47
Beat Est.
-1779.30%
-1000.00%
+41.37%
Analyst Rating
Buy

Feb 28, 2025

Ionis Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 15 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 145.951M--
--2025/Q1-- / 125.495M--
Feb 19, 20252024/Q4227.000M / 139.175M--
Nov 6, 20242024/Q3134.000M / 129.926M--
Aug 1, 20242024/Q2225.000M / 149.794M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 145.951M--
--2025/Q1-- / 125.495M--
Feb 19, 20252024/Q4227.000M / 139.175M--
Nov 6, 20242024/Q3134.000M / 129.926M--
Aug 1, 20242024/Q2225.000M / 149.794M--

Unlock Free Earnings Estimates

Ionis Pharmaceuticals Earnings Reports

  • Ionis Pharmaceuticals | 10-K: FY2024 Annual Report

    Feb 19 16:12 ET

  • Ionis Pharmaceuticals | 8-K: Ionis reports fourth quarter and full year 2024 financial results

    Feb 19 11:16 ET

  • Ionis Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 6, 2024 16:15 ET

  • Ionis Pharmaceuticals | 8-K: Ionis reports third quarter 2024 financial results

    Nov 6, 2024 11:17 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Cars.com
    CARS
    +9.73%
    Lantheus
    LNTH
    +2.55%
    Halozyme Therapeutics
    HALO
    +2.51%
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +2.27%
    Collegium Pharmaceutical
    COLL
    +2.22%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 28, 2025

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data